Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

415

Participants

Timeline

Start Date

April 26, 2011

Primary Completion Date

January 8, 2023

Study Completion Date

May 14, 2027

Conditions
Ovarian Epithelial Cancer Recurrent
Interventions
PROCEDURE

Maximal cytoreductive surgery

Maximal cytoreductive surgery

DRUG

HIPEC

HIPEC: Hyperthermic Intra-PEritoneal Chemotherapy. Administration of cisplatin at 75mg/m²

Trial Locations (33)

13273

Institut Paoli Calmettes, Marseille

14076

Centre Francois Baclesse, Caen

31052

Institut Claudius Regaud, Toulouse

33076

Institut Bergonie, Bordeaux

34298

CRLC Val d'Aurelle, Montpellier

42055

Centre Hospitalier Universitaire Saint Etienne- Hopital Nord, Saint-Etienne

44805

Ico-Centre Rene Gauducheau, Saint-Herblain

49933

Centre Paul Papin, Angers

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Lille

63011

Centre Jean Perrin, Clermont-Ferrand

67098

CHU Hautepierre, Strasbourg

69373

Centre Leon Berard, Lyon

69495

Centre Hopsitalier Lyon Sud, Lyon

75010

Hopital Lariboisiere, Paris

75020

Hopital Tenon, Paris

87042

Centre Hospitalier Universitaire Dupuytren, Limoges

94805

Institut Gustave Roussy, Villejuif

Unknown

Institut Jules Bordet, Brussels

CHU d'AMIENS, Amiens

Clinique Pasteur, Brest

Polyclinique Kéraudren, Brest

Centre hospitalier de Dijon, Dijon

CHU de Grenoble, Grenoble

Clinique Victor Hugo, Le Mans

Pôle Santé Sud, Le Mans

CHU de Lille, Lille

AP-HM - Hôpital de la Timone, Marseille

Hôpital Européen Georges Pompidou, Paris

Institut Curie, Paris

CHU - Hôpital de la Milétrie, Poitiers

Hospital Universitari Germans Trias I Pujol, Badalona

06202

Centre Hospitalier Universitaire Nice, Nice

All Listed Sponsors
lead

UNICANCER

OTHER

NCT01376752 - Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment | Biotech Hunter | Biotech Hunter